Bronchiolitis Obliterans Syndrome Market is segmented By Therapy (Budesonide/Formoterol, Montelukast, N-acetylcysteine), By Drug Class (Macrolide Antibiotics, Corticosteroids, Immunosuppressive Drugs), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Million) for the above-mentioned segments.
The major players operating in the bronchiolitis obliterans syndrome market include Zambon Pharma, Incyte Corporation, Genentech, GlaxoSmithKline, and Altavant Sciences.
Bronchiolitis Obliterans Syndrome Market